Valuation: Yuhan Corporation

Market Cap 5,280B 3.55B 3.1B 2.86B 2.64B 4.97B 342B 5.08B 34.22B 13.46B 167B 13.33B 13.04B 576B P/E 2026 *
39.3x
P/E 2027 * 25.4x
Enterprise Value 5.19B 3.49M 3.05M 2.81M 2.59M 4.89M 336M 4.99M 33.62M 13.22M 164M 13.1M 12.81M 566M EV / Sales 2026 *
2.22x
EV / Sales 2027 * 1.98x
Free-Float
64.28%
Yield 2026 *
0.79%
Yield 2027 * 0.79%
1 day+1.87%
1 week+5.04%
Current month+0.85%
1 month-9.58%
3 months-27.53%
6 months-34.38%
Current year-37.01%
1 week 66,200
Extreme 66200
71,000
1 month 65,000
Extreme 65000
80,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
136,400
3 years 52,285.71
Extreme 52285.7143
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.87%+5.04%-37.18%+24.94% 3.56B
+0.03%+3.56%+56.94%+21.19% 315B
-1.20%-2.43%+22.19%-8.40% 68.62B
+0.13%+1.80%+34.20%+92.64% 9.2B
+0.34%-0.73%+6.41%+0.09% 8.52B
-11.03%-10.66%-4.88%+14.00% 4.04B
+1.53%-1.00%-18.56%+3.79% 4.2B
+0.57%+0.18%+44.52%+64.95% 2.8B
-7.41%-0.18%+3.86%-22.49% 2.26B
-8.90%+3.21%-19.68%+27.74% 2.01B
Average -2.40%-2.15%+8.78%+21.84% 42.04B
Weighted average by Cap. -0.32%-1.87%+46.87%+17.37%

Financials

2026 *2027 *
Net sales 2,333B 1.57B 1.37B 1.27B 1.17B 2.2B 151B 2.25B 15.12B 5.95B 73.99B 5.89B 5.76B 255B 2,586B 1.74B 1.52B 1.4B 1.29B 2.44B 167B 2.49B 16.76B 6.59B 82.02B 6.53B 6.39B 282B
Net income 141B 95.1M 83.11M 76.69M 70.69M 133M 9.16B 136M 917M 361M 4.49B 357M 349M 15.44B 212B 143M 125M 115M 106M 200M 13.75B 204M 1.38B 541M 6.73B 536M 524M 23.18B
Net Debt -93.37B -62.79M -54.87M -50.64M -46.67M -87.97M -6.05B -89.92M -605M -238M -2.96B -236M -231M -10.2B -158B -106M -92.65M -85.5M -78.81M -149M -10.21B -152M -1.02B -402M -5B -398M -389M -17.21B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-07-16 ₩70,800.00 +1.87% 245,221
26-07-15 ₩69,500.00 +4.20% 279,742
26-07-14 ₩66,700.00 -2.06% 295,357
26-07-13 ₩68,100.00 -0.58% 267,788
26-07-10 ₩68,500.00 +1.63% 247,126
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
70,800.00KRW
Average target price
127,555.56KRW
Spread / Average Target
+80.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock